BreatheSuite is a Canadian connected health company founded in 2018 to help people with chronic respiratory conditions live longer, healthier lives. The BreatheSuite MDI device, which received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for prescription and over-the-counter use, is compatible with 90% of MDIs on the market to track and train proper inhaler usage. Coupled with a mobile application built on behavior change strategies, it provides tips to improve inhaler adherence and technique, and enables remote patient monitoring. Also cleared for sale in Canada, BreatheSuite works...read more